Dorsavi Ltd
dorsaVi Ltd is focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety.
The business
dorsaVi Ltd is focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Video AI, ViMove+, ViSafe+, and Research+. Video AI products provide rapid movement assessment and instant reporting. ViSafe+ offers a range of solutions designed to enhance workplace safety and reduce injuries through ergonomic risk assessment software. ViMove+ equips clinics and sports professionals with advanced movement analysis technology, using wearable sensors and biomechanical assessment tools for precise, real-time tracking of client and athlete movements. Research+ is a product designed for research professionals who demand precision motion capture and third dimensional (3D) biomechanics analysis in their work. Its wearable sensor technology enables many aspects of detailed human movement and position to be captured, quantified, and assessed.
Small Caps Research
No research on Dorsavi Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise DVL based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
dorsaVi Commences Silicon Fabrication of First RRAM-CMOS Validation Chip
dorsaVi starts silicon fabrication of its RRAM-CMOS validation chip, moving from design to wafer run and toward a 22nm program with NTU/ITRI.
dorsaVi Advances 22nm RRAM Development With CMOS Validation Chip Tape-Out
dorsaVi advances 22nm RRAM-CMOS validation tape-out, moving toward silicon manufacturing and wafer-level testing for AI, robotics, wearables.
dorsaVi Finalises RRAM-CMOS Validation Chip Design for Ultra-Edge AI
DorsaVi finalises RRAM-CMOS validation chip for ultra-edge AI; moves toward tape-out and 22nm CIM-enabled edge intelligence roadmap.
dorsaVi Licences NTU Robotics IP To Expand Into Human-Robot Collaboration
dorsaVi lands exclusive NTU Singapore license for two Human-Robot Safety IPs for 10 years, expanding from wearables to AI-enabled robotics platform.
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.